Download PDF
Semin Neurol 2007; 27(4): 331-339
DOI: 10.1055/s-2007-985335
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Gender-Specific Challenges in the Management of Epilepsy in Women

Katherine H. Noe1
  • 1Department of Neurology, Mayo Clinic Hospital, Phoenix, Arizona
Further Information

Publication History

Publication Date:
15 August 2007 (online)

    Permissions and Reprints

ABSTRACT

The management of epilepsy in women encompasses a complex interplay between seizures, sex steroid hormones, and antiepileptic drugs (AEDs). These interactions impact every aspect of the sexual and reproductive health of women with epilepsy throughout their lifetimes. Neurologists comfortable treating seizures may feel unprepared to handle questions related to reproductive health. Several cases are provided to illustrate commonly encountered queries from women with epilepsy about catamenial epilepsy, pregnancy, breast-feeding, contraception, menopause, and bone health. Available evidence is reviewed, and guidelines for management are provided.

KEYWORDS

Antiepileptic drugs - catamenial epilepsy - teratogenesis - pregnancy - contraception

REFERENCES

  • 1 Quality Standards Subcommittee of the American Academy of Neurology . Practice parameter: management issues for women with epilepsy.  Neurology. 1998;  51 944-948
    PubMedSearch in Google Scholar
  • 2 Seale C G, Morrell M J, Nelson L, Druzin M L. Analysis of prenatal and gestational care given to women with epilepsy.  Neurology. 1998;  51 1039-1045
    PubMedSearch in Google Scholar
  • 3 Morrell M J, Sarto G E, Shafer P O, Borda E A, Herzog A, Callanan M. Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare providers.  J Womens Health Gend Based Med. 2000;  9 959-965
    CrossrefPubMedSearch in Google Scholar
  • 4 Long L, Mantouris G. Knowledge of women's issues and epilepsy (KOWIE-II), a survey of healthcare professionals.  Epilepsy Behav. 2005;  6 90-93
    CrossrefPubMedSearch in Google Scholar
  • 5 Klein P, van Passel-Clark L M, Pezzullo J C. Onset of epilepsy at the time of menarche.  Neurology. 2003;  60 495-497
    PubMedSearch in Google Scholar
  • 6 Herzog A G, Klein P, Ransil B J. Three patterns of catamenial epilepsy.  Epilepsia. 1997;  38 1082-1088
    PubMedSearch in Google Scholar
  • 7 Herzog A G, Harden C L, Liporace J et al.. Frequency of catamenial seizure exacerbation in women with localization related epilepsy.  Ann Neurol. 2004;  56 431-434
    CrossrefPubMedSearch in Google Scholar
  • 8 Scharfman H E, MacLusky N J. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.  Epilepsia. 2006;  47 1423-1440
    CrossrefPubMedSearch in Google Scholar
  • 9 Morrell M J, Giudice L, Flynn K L et al.. Predictors of ovulatory failure in women with epilepsy.  Ann Neurol. 2002;  52 704-711
    CrossrefPubMedSearch in Google Scholar
  • 10 Lim L L, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy.  Epilepsia. 2001;  42 746-749
    CrossrefPubMedSearch in Google Scholar
  • 11 Mattson R H, Cramer J A, Caldwell B V, Siconolfi B C. Treatment of seizures with medroxyprogesterone acetate: preliminary report.  Neurology. 1984;  34 1255-1258
    PubMedSearch in Google Scholar
  • 12 Herzog A G. Progesterone therapy in women with complex partial and secondary generalized seizures.  Neurology. 1995;  45 1660-1662
    PubMedSearch in Google Scholar
  • 13 Herzog A G. Progesterone therapy in women with epilepsy: a three year follow-up.  Neurology. 1999;  52 1917-1918
    PubMedSearch in Google Scholar
  • 14 Speidel B D, Meadow S R. Maternal epilepsy and abnormalities of the fetus and newborn.  Lancet. 1972;  2 839-843
    PubMedSearch in Google Scholar
  • 15 Yerby M S. Management issues for women with epilepsy: neural tube defects and folic acid supplementation.  Neurology. 2003;  61(suppl 2) S23-S26
    PubMedSearch in Google Scholar
  • 16 Kaneko S, Battino D, Andermann E et al.. Congenital malformations due to antiepileptic drugs.  Epilepsy Res. 1999;  33 145-158
    CrossrefPubMedSearch in Google Scholar
  • 17 Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in the offspring of women with epilepsy.  Neurology. 2003;  60 575-579
    CrossrefPubMedSearch in Google Scholar
  • 18 Morrow J, Russell A, Guthrie E et al.. Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.  J Neurol Neurosurg Psychiatry. 2006;  77 193-198
    CrossrefPubMedSearch in Google Scholar
  • 19 Artama M, Ritvanen A, Gissler M, Isojarvi J, Auvinen A. Congenital structural anomalies in offspring of women with epilepsy: a population based cohort study in Finland.  Int J Epidemiol. 2006;  35 280-287
    PubMedSearch in Google Scholar
  • 20 Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population based register study.  Acta Paediatr. 2004;  93 174-176
    CrossrefPubMedSearch in Google Scholar
  • 21 Wyszynski D F, Nambisan M, Surve T et al.. Increased rate of major malformations in offspring exposed to valproate during pregnancy.  Neurology. 2005;  64 961-965
    CrossrefPubMedSearch in Google Scholar
  • 22 Vajda F J, Eadie M J. Maternal valproate dosage and fetal malformations.  Acta Neurol Scand. 2005;  112 137-143
    CrossrefPubMedSearch in Google Scholar
  • 23 Vajda F J, Hitchcock A, Graham J et al.. Fetal malformations and seizure control: 52 months of data of the Australian Pregnancy Registry.  Eur J Neurol. 2006;  13 645-654
    CrossrefPubMedSearch in Google Scholar
  • 24 Adab N, Kini U, Vinten J et al.. The longer term outcome of children born to mothers with epilepsy.  J Neurol Neurosurg Psychiatry. 2004;  75 1575-1583
    CrossrefPubMedSearch in Google Scholar
  • 25 Holmes L B, Wyszynski D R, Baldwin E J, Haebecker E, Glassman L H, Smith C R. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy [abstract].  Birth Defects Res Part A Clin Mol Teratol. 2006;  76 318
    PubMedSearch in Google Scholar
  • 26 Samren E B, van Duijn C M, Kock S et al.. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.  Epilepsia. 1997;  38 981-990
    PubMedSearch in Google Scholar
  • 27 Yerby M S, Kaplan P, Tran T. Risks and management of pregnancy in women with epilepsy.  Cleve Clin J Med. 2004;  71(suppl 2) S25-S37
    PubMedSearch in Google Scholar
  • 28 EURAP Investigators . Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.  Neurology. 2006;  66 354-360
    CrossrefPubMedSearch in Google Scholar
  • 29 Teramo K, Hiilesmaa V K. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In: Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D Epilepsy, Pregnancy and the Child. New York; Raven Press 1982: 53-59
    Search in Google Scholar
  • 30 Teramo K, Hiilesmaa V, Saarikoski A B. Fetal heart rate during a maternal grand mal epileptic seizure.  J Perinat Med. 1979;  7 3-6
    PubMedSearch in Google Scholar
  • 31 Nei M, Daly S, Liporace J. A maternal partial complex seizure in labor can affect fetal heart rate.  Neurology. 1998;  51 904-906
    PubMedSearch in Google Scholar
  • 32 Sahoo S, Klein P. Maternal complex partial seizure associated with fetal distress.  Arch Neurol. 2005;  62 1304-1305
    CrossrefPubMedSearch in Google Scholar
  • 33 Centers for Disease Control . Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.  MMWR Recomm Rep. 1992;  41 1-7
    PubMedSearch in Google Scholar
  • 34 Section of Breastfeeding, American Academy of Pediatrics . Breastfeeding and the use of human milk.  Pediatrics. 2005;  115 496-506
    CrossrefPubMedSearch in Google Scholar
  • 35 Henshaw S K. Unintended pregnancy in the United States.  Fam Plann Perspect. 1998;  30 24-29
    CrossrefPubMedSearch in Google Scholar
  • 36 Fairgrieve S D, Jackson M, Jonas P et al.. Population based prospective study of the care of women with epilepsy in pregnancy.  BMJ. 2000;  321 674-675
    PubMedSearch in Google Scholar
  • 37 Krauss G L, Brandt J, Cambell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologist and obstetricians.  Neurology. 1996;  46 1534-1539
    CrossrefPubMedSearch in Google Scholar
  • 38 Bensyl D M, Iuliano D A, Carter M, Santelli J, Gilbert B C. Contraceptive use: United States and territories, behavioral risk factor surveillance system, 2002.  MMWR Surveill Summ. 2005;  54 1-72
    PubMedSearch in Google Scholar
  • 39 O'Brien M D, Guillebaud J. Contraception for women with epilepsy.  Epilepsia. 2006;  47 1419-1422
    CrossrefPubMedSearch in Google Scholar
  • 40 Thorneycroft I, Klein P, Simon J. The impact of antiepileptic drug therapy on steroidal contraceptive efficacy.  Epilepsy Behav. 2006;  9 31-39
    PubMedSearch in Google Scholar
  • 41 Harden C L, Leppik I. Optimizing therapy of seizures in women who use oral contraceptives.  Neurology. 2006;  67(suppl 4) S56-S58
    PubMedSearch in Google Scholar
  • 42 De Souza A, Brechin S, Penney G. The member's enquiry service: frequently asked questions.  J Fam Plann Reprod Health Care. 2004;  30 57-58
    CrossrefPubMedSearch in Google Scholar
  • 43 Bounds W, Guillebaud J. Observational series on women using contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs.  J Fam Plann Reprod Health Care. 2002;  28 78-80
    CrossrefPubMedSearch in Google Scholar
  • 44 Dirubbo N E. Counsel your patients about contraceptive options.  Nurse Pract. 2006;  31 40-44
    CrossrefPubMedSearch in Google Scholar
  • 45 Sabers A, Ohman I, Christensens J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels.  Neurology. 2003;  61 570-571
    CrossrefPubMedSearch in Google Scholar
  • 46 Klein P, Serje A, Pezzullo J C. Premature ovarian failure in women with epilepsy.  Epilepsia. 2001;  42 1584-1589
    CrossrefPubMedSearch in Google Scholar
  • 47 Harden C L, Koppel B S, Herzog A G et al.. Seizure frequency is associated with age at menopause in women with epilepsy.  Neurology. 2003;  61 451-455
    PubMedSearch in Google Scholar
  • 48 Harden C L, Pulver M C, Ravdin L, Jacobs A R. The effect of menopause and perimenopause on the course of epilepsy.  Epilepsia. 1999;  40 1402-1407
    PubMedSearch in Google Scholar
  • 49 Abbasi F, Krumholz A, Kittner S J, Langenberg P. Effects of menopause on seizures in women with epilepsy.  Epilepsia. 1999;  40 205-210
    PubMedSearch in Google Scholar
  • 50 Hulley S, Grady D, Bush T et al.. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.  JAMA. 1998;  280 605-613
    CrossrefPubMedSearch in Google Scholar
  • 51 Rossouw J E, Anderson G L, Prentice R L et al.. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.  JAMA. 2002;  288 321-333
    CrossrefPubMedSearch in Google Scholar
  • 52 Harden C L, Herzog A G, Nikolov B G et al.. Hormone replacement therapy in women with epilepsy: a randomized double-blind placebo-controlled study.  Epilepsia. 2006;  47 1447-1451
    CrossrefPubMedSearch in Google Scholar
  • 53 U.S. Department of Health and Human Services .Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD; U.S. Department of Health and Human Services, Public Health Service, Office of Surgeon General 2004
    Search in Google Scholar
  • 54 Empana J P, Dargent-Molina P, Breart G. Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study.  J Am Geriatr Soc. 2004;  52 685-690
    CrossrefPubMedSearch in Google Scholar
  • 55 Valmadrid C, Voorhees C, Litte B, Schneyer C. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy.  Arch Neurol. 2001;  58 1369-1374
    CrossrefPubMedSearch in Google Scholar
  • 56 Cummings S R, Nevitt M C, Browner W S et al.. Risk factors for hip fracture in white women.  N Engl J Med. 1995;  332 767-773
    CrossrefPubMedSearch in Google Scholar
  • 57 Van Staa T P, Leufkens H G, Cooper C. Utility of medical and drug history in fracture risk prediction among men and women.  Bone. 2002;  31 508-514
    CrossrefPubMedSearch in Google Scholar
  • 58 Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy.  Acta Neurol Scand. 1999;  99 269-275
    CrossrefPubMedSearch in Google Scholar
  • 59 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs.  Epilepsia. 2004;  45 1330-1337
    CrossrefPubMedSearch in Google Scholar
  • 60 Souverein P C, Webb D J, Petri H, Weil J, Van Staa T P, Egberts T. Incidence of fractures among epilepsy patients: a population-based prospective cohort study in the General Practice Research Database.  Epilepsia. 2005;  46 304-310
    CrossrefPubMedSearch in Google Scholar
  • 61 Petty S J, Paton L M, O'Brien T J et al.. Effect of antiepileptic medication on bone mineral measures.  Neurology. 2005;  65 1358-1363
    CrossrefPubMedSearch in Google Scholar
  • 62 Pack A M, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs.  Cleve Clin J Med. 2004;  71(suppl 2) S42-S48
    PubMedSearch in Google Scholar
  • 63 Valimaki M J, Tiihonen M, Laitinen K et al.. Bone mineral density measured by dual energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.  J Bone Miner Res. 1994;  9 631-637
    PubMedSearch in Google Scholar
  • 64 Ensrud K E, Walzak T S, Blackwell T, Ensrued E R, Bowman P J, Stone K L. Antiepileptic drug use increases rates of bone loss in older women: a prospective study.  Neurology. 2004;  62 2051-2057
    PubMedSearch in Google Scholar
  • 65 Pack A M, Morrell M J, Marcus R et al.. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.  Ann Neurol. 2005;  57 252-257
    CrossrefPubMedSearch in Google Scholar
  • 66 Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal and postpubertal patients receiving carbamazepine.  Epilepsia. 2002;  43 1488-1492
    CrossrefPubMedSearch in Google Scholar
  • 67 Sheth R D, Wesolowski C A, Jacob J C et al.. Effect of carbamazepine and valproate on bone mineral density.  J Pediatr. 1995;  127 256-262
    PubMedSearch in Google Scholar
  • 68 Mintzer S, Bopana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.  Epilepsia. 2006;  47 510-515
    CrossrefPubMedSearch in Google Scholar
  • 69 Sato Y, Kondo I, Ishida S et al.. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy.  Neurology. 2001;  57 445-449
    CrossrefPubMedSearch in Google Scholar
  • 70 Boluk A, Guzelipek M, Savli H, Temel I, Ozisik H I, Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients.  Pharmacol Res. 2004;  50 93-97
    CrossrefPubMedSearch in Google Scholar
  • 71 Burke M S. Current roles and realities of noninvasive assessment of osteoporosis.  Curr Opin Endocrinol Diabetes. 2004;  11 330-337
    CrossrefPubMedSearch in Google Scholar
  • 72 Pack A M, Olarte L S, Morrell M J, Flaster E, Resor S R, Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs.  Epilepsy Behav. 2003;  4 169-174
    CrossrefPubMedSearch in Google Scholar
  • 73 Farhat G, Yamout B, Mikati A, Demirjian S, Sawaya R, Fuleihan G E. Effect of antiepileptic drugs on bone density in ambulatory patients.  Neurology. 2002;  58 1348-1353
    CrossrefPubMedSearch in Google Scholar
  • 74 Binkley N, Bilezikian J P, Kendler D L et al.. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference.  J Clin Densitom. 2006;  9 4-14
    CrossrefPubMedSearch in Google Scholar
  • 75 Harden C L. Menopause and bone density issues for women with epilepsy.  Neurology. 2003;  61(suppl 2) S16-S22
    PubMedSearch in Google Scholar
  • 76 Mikati M A, Dib L, Yamout B, Sawaya R, Rahi A C, Fuleihan G E. Two randomized vitamin D trials in ambulatory patients on anticonvulsants.  Neurology. 2006;  67 2005-2014
    CrossrefPubMedSearch in Google Scholar
  • 77 Drezner M K. Treatment of anticonvulsant drug-induced bone disease.  Epilepsy Behav. 2004;  5 S41-S47
    CrossrefPubMedSearch in Google Scholar

Katherine H NoeM.D Ph.D. 

Department of Neurology

5 East, Mayo Clinic Hospital, 5777 East Mayo Boulevard, Phoenix, AZ 85054